1.
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease
by Campbell, Duncan J
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.69-74
2.
The Burden of Blood Pressure-Related Disease: A Neglected Priority for Global Health
by Perkovic, Vlado
Hypertension (Dallas, Tex. 1979), 2007-12, Vol.50 (6), p.991-997
3.
Blood Pressure Lowering for the Secondary Prevention of Myocardial Infarction and Stroke
by MacMahon, Stephen
Hypertension (Dallas, Tex. 1979), 1997-02, Vol.29 (2), p.537-538
4.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and...
by Van Der Leeuw, Joep
Hypertension (Dallas, Tex. 1979), 2015-01-01, Vol.65 (1), p.115-121
5.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
by HARRAP, Stephen B
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (3), p.297-303
6.
Alcohol consumption and hypertension
by MacMahon, S
Hypertension (Dallas, Tex. 1979), 1987-02, Vol.9 (2), p.111-121
7.
Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens: An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials
by Bell, Katy J.L
Hypertension (Dallas, Tex. 1979), 2010-09, Vol.56 (3), p.533-539
8.
Antihypertensive Drug Treatment Potential, Expected, and Observed Effects on Stroke and on Coronary Heart Disease
by MacMahon, Stephen
Hypertension (Dallas, Tex. 1979), 1989-05, Vol.13 (5 Suppl I), p.I-45-I-50
9.
Controlled Clinical Trials of Drug Treatment for Hypertension A Review
by Cutler, Jeffrey A
Hypertension (Dallas, Tex. 1979), 1989-05, Vol.13 (5 Suppl I), p.I-36-I-44
